Justin Kuehn, the lead attorney on the investigation, is calling for long-term TGTX stockholders to come forward regarding their holdings. The firm frames this action as a move to uphold financial market integrity, offering free consultations to those who believe the board’s conduct has compromised shareholder value. Kuehn Law has stated it will cover all litigation costs for participating investors, emphasizing that time may be limited for stakeholders to assert their rights in this matter. While the firm highlights the potential for damages, they note that previous legal outcomes do not serve as a guarantee for future results.
Kuehn Law Launches Inquiry into TG Therapeutics Leadership
Shareholders of TG Therapeutics, Inc. are under scrutiny as New York-based Kuehn Law, PLLC, investigates potential breaches of fiduciary duty by the company’s officers and directors. The inquiry centers on allegations of self-dealing, opening a window for long-term investors to pursue legal remedies or demand corporate governance reforms.
Comments (0)
No comments yet. Be the first!